Concurrent Radiotherapy with Carboplatin and Cetuximab for the Treatment of Medically Compromised Patients with Locoregionally Advanced Head and Neck Squamous Cell Carcinoma

Background: Cetuximab (Cx) + radiation therapy (RT) is well-tolerated and has improved survival in patients (pts) with locoregionally advanced head and neck squamous cell carcinomas (LA-HNSCC). However, its efficacy when compared to HD-DDP + RT has been questioned. At our institution, low-dose weekl...

Descripción completa

Detalles Bibliográficos
Autores principales: Saigal, Kunal, Santos, Edgardo S., Tolba, Khaled, Kwon, Deukwoo, Elsayyad, Nagy, Abramowitz, Matthew C., Mandalia, Amar, Samuels, Michael Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074875/
https://www.ncbi.nlm.nih.gov/pubmed/25072020
http://dx.doi.org/10.3389/fonc.2014.00165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074875/
https://www.ncbi.nlm.nih.gov/pubmed/25072020
http://dx.doi.org/10.3389/fonc.2014.00165

Ejemplares similares